201 results
Page 9 of 11
8-K
EX-99.3
azxff uyx
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
8-K
EX-2.1
5fan0
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
8-K
EX-10.1
oqyqpxbns abc
8 Jan 21
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
7:03am
425
EX-99.3
tthd6w0 ca5b0diq
8 Jan 21
Business combination disclosure
7:02am
425
EX-2.1
oo2ocl 842i7w6b0xa
8 Jan 21
Business combination disclosure
7:02am
425
EX-10.1
hn2w6tltfb833im
8 Jan 21
Business combination disclosure
7:02am
8-K
dnq67dt1 hb06mu40
4 Jan 21
Submission of Matters to a Vote of Security Holders
2:10pm
DEF 14A
mi8icas pis
4 Dec 20
Definitive proxy
5:23pm
10-K
kwap9k6 3wsf
24 Mar 20
Annual report
12:00am
10-Q
nxy3bm4y9bwoquj2wd
7 Aug 19
Quarterly report
4:32pm
8-K
EX-99.1
ujto83ctis rvdv
30 May 19
GX Acquisition Corp. Index to Financial Statement
4:11pm
8-K
EX-1.1
qmjqk9son0oli8 u5d
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-10.3
a89jv0p
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-3.1
0tmdo9l
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-4.1
3gd1n6eqm jpokii
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
8-K
EX-3.1
94ogkdoq
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm